SITANORM 50 TAB

About

Sitagliptin is an oral antidiabetic medication that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Its primary mechanism of action involves inhibiting the enzyme DPP-4, which is responsible for the rapid breakdown of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By preserving these incretins, sitagliptin enhances the body's natural ability to regulate blood glucose levels. This leads to increased glucose-dependent insulin secretion from pancreatic beta cells, meaning insulin is released more effectively when blood sugar is high. Concurrently, it reduces glucagon secretion from pancreatic alpha cells, ultimately improving both fasting and postprandial hyperglycemia in patients with type 2 diabetes mellitus. It is often used when diet and exercise alone are insufficient to achieve adequate glycemic control.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control.
• Reduction of HbA1c levels.
• Used as an adjunct to diet and exercise.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Effective blood glucose lowering.
• Improved insulin secretion.
• Reduced glucagon levels.
• Generally weight-neutral.
• Low risk of hypoglycemia (as monotherapy).
• Well-tolerated with a favorable safety profile.

Side Effects

• Headache
• Upper respiratory tract infection
• Sore throat
• Nausea
• Diarrhea
• Abdominal pain
• Pancreatitis (rare, but serious)
• Joint pain
• Allergic reactions (rash, hives, angioedema)
• Kidney problems (rare)
• Constipation
• Dizziness

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable. No specific interactions are typically noted, but excessive intake should always be avoided for general health.
• Pregnancy - Generally not recommended during pregnancy. Consult your doctor, as alternative treatments may be necessary to manage diabetes safely during this period.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if sitagliptin passes into breast milk. Discuss with your healthcare provider.
• Liver - No dose adjustment is typically needed for mild to moderate liver impairment. Use with caution in severe impairment.
• Kidney - Dose adjustment is required for patients with moderate to severe renal impairment and end-stage renal disease. Not recommended for severe impairment without dose modification.
• Lung - Generally safe for use in patients with lung conditions. No specific precautions related to lung function are typically required.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.